Can I Take CoQ10 with Cialis (Tadalafil)?

How Tadalafil Works and Why Supplements Matter

Tadalafil is a selective phosphodiesterase type 5 (PDE5) inhibitor approved by the FDA for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension at doses ranging from 2.5 mg to 20 mg [1]. By blocking PDE5, it prevents the breakdown of cyclic guanosine monophosphate (cGMP), which relaxes smooth muscle in the corpus cavernosum and in pulmonary and systemic vasculature. That vascular relaxation is the source of both its therapeutic effect and its clinically relevant hemodynamic footprint.

Men taking Cialis are often also managing related metabolic conditions. Many are on statins for cardiovascular risk, and a substantial number reach for supplements like CoQ10 hoping to support erectile function or general cardiovascular health. Understanding exactly what happens when these compounds overlap matters for patient safety.

Tadalafil's Metabolic Pathway

Tadalafil is almost entirely metabolized in the liver by the cytochrome P450 enzyme CYP3A4, producing an inactive catechol metabolite [1]. Drugs or supplements that strongly inhibit CYP3A4, such as ketoconazole or ritonavir, can raise tadalafil plasma concentrations significantly. The FDA label for Cialis specifically warns against combining it with potent CYP3A4 inhibitors and recommends a maximum dose of 10 mg every 72 hours with moderate inhibitors such as erythromycin [1].

CoQ10 (ubiquinone) does not inhibit CYP3A4 at any dose studied in human pharmacokinetic trials. A 2019 review in the International Journal of Molecular Sciences found no evidence that CoQ10 alters the activity of major cytochrome P450 isoforms at supplemental doses of 100 to 600 mg per day [2]. This is the key point: the interaction between CoQ10 and tadalafil is not pharmacokinetic.

Why Pharmacodynamics Still Deserve Attention

Pharmacodynamic interactions occur when two agents affect the same physiological endpoint through different mechanisms. Both tadalafil and CoQ10 lower blood pressure, though by very different routes.

Tadalafil reduces peripheral vascular resistance via the nitric oxide / cGMP pathway. Its mean maximum decrease in seated systolic blood pressure, measured against placebo in clinical studies cited in the FDA label, is approximately 8.4 mmHg for the 20 mg dose [1]. CoQ10 works through a separate mechanism: it restores mitochondrial electron transport chain efficiency and reduces oxidative stress in endothelial cells, which improves endothelial nitric oxide synthase (eNOS) function. A 2007 meta-analysis by Rosenfeldt et al. (12 randomized trials, N=362) found CoQ10 supplementation reduced systolic BP by a mean of 16.6 mmHg and diastolic BP by 8.2 mmHg vs. Placebo [3].

Added together in a susceptible individual, those effects could push blood pressure lower than intended.

What the Clinical Evidence Shows About CoQ10 and Erectile Function

CoQ10 has been studied as a standalone therapy for erectile dysfunction, with results relevant to men who already take tadalafil.

The Mancini Trial

Mancini et al. (2012) conducted a randomized, double-blind, placebo-controlled crossover trial (N=38) in men with erectile dysfunction. Participants received CoQ10 200 mg per day or placebo for 12 weeks, then crossed over after a 4-week washout. CoQ10 supplementation produced a statistically significant improvement in the International Index of Erectile Function (IIEF) score compared with placebo (P<0.05) [4]. The authors attributed this to improved penile endothelial function secondary to higher intracellular CoQ10 and reduced superoxide production.

CoQ10 in Cardiovascular Comorbidity

Many men with erectile dysfunction have underlying endothelial dysfunction driven by hypertension, dyslipidemia, or type 2 diabetes. The Q-SYMBIO trial (N=420), a randomized controlled trial in chronic heart failure patients, found that CoQ10 300 mg per day for 2 years significantly reduced major adverse cardiovascular events compared with placebo (hazard ratio 0.50, 95% CI 0.27 to 0.95, P=0.036) [5]. This trial did not specifically study erectile dysfunction, but the cardiovascular improvements it demonstrated are mechanistically relevant: healthier endothelium supports better penile perfusion regardless of PDE5 inhibitor use.

Does CoQ10 Add Benefit on Top of Tadalafil?

No large randomized trial has directly compared CoQ10 plus tadalafil against tadalafil alone for erectile dysfunction. This is a genuine gap in the literature. Based on the separate mechanisms, CoQ10 addressing upstream endothelial oxidative stress while tadalafil acts downstream at the cGMP level, there is a plausible rationale for additive benefit. But plausible is not proven.

HealthRX Clinical Framework: Stratifying CoQ10 + Tadalafil by Patient Profile

| Patient Profile | Interaction Risk | CoQ10 Likely Useful? | Key Monitoring Point | |---|---|---|---| | ED only, no antihypertensives, normal BP | Low | Possibly (endothelial support) | Baseline BP once | | ED + statin use | Low | Yes (replenish statin depletion) | CoQ10 plasma level optional | | ED + antihypertensive (ACE inhibitor / ARB) | Low-moderate | Yes, with awareness | Seated BP, symptoms of dizziness | | ED + alpha-blocker (tamsulosin, doxazosin) | Moderate | Use caution | Seated and standing BP | | Pulmonary arterial hypertension on tadalafil 40 mg | Moderate | Discuss with cardiologist | Close BP telemonitoring |

The Statin-CoQ10 Depletion Connection

This is where the overlap between CoQ10 and the Cialis patient population becomes most clinically meaningful. Statins, used by a very large share of men who also take tadalafil for cardiovascular-associated erectile dysfunction, inhibit HMG-CoA reductase and thereby block the mevalonate pathway. CoQ10 is biosynthesized through that same pathway, so statins reliably reduce plasma CoQ10 levels.

How Much Do Statins Deplete CoQ10?

A systematic review by Deichmann et al. (2010) found that atorvastatin, simvastatin, and rosuvastatin all significantly reduced plasma CoQ10 by 16 to 54% depending on dose and duration [6]. The depletion is dose-dependent. A patient on atorvastatin 80 mg per day will have a more substantial reduction than one on pravastatin 10 mg per day.

Does Depletion Matter Clinically?

The jury remains partially out. The American College of Cardiology does not currently recommend routine CoQ10 supplementation for all statin users, partly because clinical trial evidence for statin-associated myopathy prevention has been mixed [7]. The 2019 IAMUSCLE trial found no significant reduction in statin-associated muscle symptoms with CoQ10 600 mg per day vs. Placebo over 8 weeks in N=120 participants [8]. Conversely, some smaller trials have shown benefit in specific subpopulations with documented low plasma CoQ10 at baseline.

For men on both a statin and tadalafil, the practical takeaway is this: CoQ10 supplementation at 100 to 200 mg per day is not harmful and may partially restore depleted levels. It does not interact dangerously with either drug.

Blood Pressure: The One Real Concern

The most clinically actionable finding in this combination is the additive blood pressure effect.

Who Is Actually at Risk?

Men taking tadalafil 5 mg once daily for BPH or ED, a calcium channel blocker like amlodipine for hypertension, and CoQ10 300 mg per day could theoretically see systolic BP drop 20 to 30 mmHg more than baseline, enough to cause lightheadedness or syncope on standing. This is not a theoretical exercise. The FDA label for Cialis explicitly warns that combining tadalafil with antihypertensives including amlodipine produced a mean additional reduction of 8 mmHg systolic in controlled clinical pharmacology studies [1].

Alpha-blockers carry the highest co-administration risk with tadalafil. Tamsulosin 0.4 mg and tadalafil 10 mg together produced mean maximum decreases in standing systolic BP of 6.1 mmHg in FDA-reviewed pharmacology data [1]. Adding CoQ10 on top of that combination warrants a brief blood pressure check before committing to long-term supplementation.

Practical Blood Pressure Monitoring Steps

1. Measure seated BP at rest before starting CoQ10.
2. Recheck at 4 weeks after reaching a stable CoQ10 dose (usually 100 to 200 mg with a meal).
3. Ask about symptoms of orthostatic hypotension: dizziness on standing, palpitations, or near-fainting.
4. If systolic BP falls below 90 mmHg or the patient reports symptoms, reduce CoQ10 dose by 50% before discontinuing tadalafil, since CoQ10 has the more flexible dosing schedule.

Pharmacokinetics: Timing, Absorption, and Dosing

Does Timing of CoQ10 Matter Relative to Tadalafil?

No dose-separation requirement exists for this combination. Because the interaction is pharmacodynamic rather than pharmacokinetic, taking CoQ10 at breakfast and tadalafil at a different time of day provides no protective benefit regarding drug metabolism. Separating doses does not reduce the possibility of overlapping blood pressure effects either, since CoQ10's antihypertensive action persists across the day when taken consistently.

CoQ10 is fat-soluble. Absorption improves significantly when taken with a meal containing dietary fat. A pharmacokinetics study published in the Journal of Nutritional Science and Vitaminology found that CoQ10 bioavailability increased approximately 3-fold when taken with a meal vs. In a fasted state [9]. Take it with breakfast or dinner. The specific timing relative to tadalafil is irrelevant.

CoQ10 Forms: Ubiquinol vs. Ubiquinone

CoQ10 is sold as ubiquinone (oxidized form) and ubiquinol (reduced, active form). Ubiquinol has higher bioavailability in older adults, particularly those over age 50. A crossover pharmacokinetic study (N=12) found plasma CoQ10 AUC was 4.7-fold higher with ubiquinol 150 mg vs. Ubiquinone 150 mg in men with documented low baseline CoQ10 [10]. For men over 50 on statins, ubiquinol may be the more practical choice at 100 to 200 mg daily.

Tadalafil Dosing Context

The on-demand dose of tadalafil (10 mg or 20 mg) has a half-life of approximately 17.5 hours, meaning it remains pharmacologically active for roughly 36 hours post-dose. The once-daily dose of 2.5 mg or 5 mg maintains relatively steady plasma concentrations. In both cases, CoQ10's blood pressure effect is co-present whenever the supplement is taken consistently, which is the clinically relevant scenario.

Drug Interaction Databases: What They Report

Natural Medicines Comprehensive Database (the professional gold standard for supplement-drug interaction checking) classifies the CoQ10-tadalafil interaction as having "insufficient evidence" for a clinically meaningful interaction, with a monitoring flag for additive blood pressure reduction [11]. No major interaction is listed.

The Mayo Clinic drug interaction checker does not identify a contraindication between CoQ10 and tadalafil, though it does note that CoQ10 combined with blood pressure medications warrants attention.

Neither database lists a pharmacokinetic mechanism. Both treat the combination as generally safe with standard blood pressure awareness.

What to Tell Your Prescriber

Transparency with your prescribing clinician remains the right approach regardless of how benign a supplement appears. Three specific points are worth raising:

First, confirm your current resting BP is well-controlled before adding CoQ10 at doses above 200 mg per day. Men whose systolic pressure already runs at 100 to 110 mmHg on tadalafil are the ones most likely to feel dizzy with additional blood pressure lowering.

Second, if you take an alpha-blocker such as tamsulosin for BPH alongside tadalafil, the FDA label already requires caution with that specific pairing [1]. Adding CoQ10 extends the total antihypertensive load by a modest additional margin.

Third, plasma CoQ10 testing is available and can confirm whether your levels are genuinely low, particularly relevant for men on high-dose statins. A plasma CoQ10 level below 0.5 mcg/mL is considered deficient in most laboratory reference ranges.

The American Urological Association 2018 guidelines on erectile dysfunction do not specifically address CoQ10 supplementation, but they do acknowledge the importance of addressing cardiovascular risk factors and endothelial health as part of comprehensive ED management [12]. CoQ10 supplementation sits comfortably within that framework.

As the Endocrine Society's clinical practice guideline on male hypogonadism notes, "treatment of erectile dysfunction should address modifiable vascular and metabolic risk factors alongside PDE5 inhibitor therapy" [13]. CoQ10's mechanism of supporting mitochondrial function and reducing oxidative stress in endothelial tissue aligns directly with that recommendation.

Special Populations

Men with Pulmonary Arterial Hypertension

Tadalafil 40 mg (Adcirca) is approved for pulmonary arterial hypertension. At that dose, the hemodynamic effects are substantially larger than at ED doses. CoQ10 has been studied in heart failure and pulmonary conditions, but its use alongside high-dose tadalafil for PAH requires specialist oversight. The Q-SYMBIO trial's 300 mg daily CoQ10 dose produced measurable cardiac output improvements [5], and those changes combined with high-dose tadalafil's pulmonary vasodilation warrant close cardiopulmonary monitoring.

Men with Diabetes

Type 2 diabetes is one of the most common comorbidities in men with ED. A randomized controlled trial by Hamilton et al. (2009, N=64) found CoQ10 200 mg per day for 12 weeks improved HbA1c by 0.4% and reduced oxidative stress markers vs. Placebo in type 2 diabetic patients [14]. Diabetic men on tadalafil may gain additional metabolic benefit from CoQ10, and the interaction risk profile does not change in this population.